General Information of Drug (ID: DMWL9PF)

Drug Name
NSC-364432
Synonyms SarCNU; Sarcosinamide nitrosourea
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C6H11ClN4O3
Canonical SMILES
CN(CC(=O)N)C(=O)N(CCCl)N=O
InChI
InChI=1S/C6H11ClN4O3/c1-10(4-5(8)12)6(13)11(9-14)3-2-7/h2-4H2,1H3,(H2,8,12)
InChIKey
HYHJFNXFVPGMBI-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
100773
CAS Number
81965-43-7
UNII
BHB013S3MO
DrugBank ID
DB11688
TTD ID
D0D1EV
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT00036660) SarCNU in Treating Patients With Recurrent Malignant Glioma. U.S. National Institutes of Health.